NasdaqCM - Nasdaq Real Time Price • USD
GeoVax Labs, Inc. (GOVX)
As of 9:49 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -3.15 | -3.29 | -6.56 | -3.96 |
| Low Estimate | -5.56 | -5.82 | -10.03 | -3.96 |
| High Estimate | -0.74 | -0.77 | -3.09 | -3.96 |
| Year Ago EPS | -2.25 | -3.3 | -14.29 | -6.56 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -3.05 | -2.47 | -3.6 | -2.78 |
| EPS Actual | -2.25 | -3.3 | -4.8 | -13.6 |
| Difference | 0.8 | -0.83 | -1.2 | -10.82 |
| Surprise % | 26.20% | -33.60% | -33.30% | -389.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -3.15 | -3.29 | -6.56 | -3.96 |
| 7 Days Ago | -3.15 | -3.29 | -6.56 | -3.96 |
| 30 Days Ago | -3.15 | -3.29 | -6.56 | -3.96 |
| 60 Days Ago | -3 | -2.85 | -9.96 | -2.18 |
| 90 Days Ago | -0.2 | -0.19 | -0.77 | -0.7 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | GOVX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -40.00% | -- | -- | 0.80% |
| Next Qtr. | 0.30% | -- | -- | 9.60% |
| Current Year | 54.10% | -- | -- | 4.50% |
| Next Year | 39.60% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Related Tickers
VRAX Virax Biolabs Group Limited
0.7397
+9.94%
QNRX Quoin Pharmaceuticals, Ltd.
0.7400
+1.37%
KA Kineta, Inc.
0.5000
+2.46%
KPRX Kiora Pharmaceuticals, Inc.
0.5011
-1.75%
ONCO Onconetix, Inc.
0.1324
+2.32%
LIXT Lixte Biotechnology Holdings, Inc.
3.4500
+1.17%
LUMO Lumos Pharma, Inc.
2.6500
+1.15%
HOTH Hoth Therapeutics, Inc.
1.1800
0.00%
BVNRY Bavarian Nordic A/S
6.92
0.00%
REVB Revelation Biosciences, Inc.
2.3299
+5.43%